Author

Aaron Stahl

Observed names: A Stahl, A. Stahl, Stahl, Aaron

Institution: Natural and Medical Sciences Institute

Observed institutions: Natural and Medical Sciences Institute, University of Tübingen

ORCID: 0000-0003-3616-9564

Observed ORCIDs: 0000-0003-3616-9564, 0000-0003-3170-1101

OpenAlex ID: A5068734929

The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma

2024 · Stephan Spahn, Fabian Kleinhenz, et al. · Nature Communications · 27

PDF

Patient iPSC-derived neural progenitor cells display aberrant cell cycle control, p53, and DNA damage response protein expression in schizophrenia

2024 · Aaron Stahl, Johanna Heider, et al. · BMC Psychiatry · 13

PDF

Discovery of PXR Antagonist MI891 and PXR Degrader MI1013 and Their Roles in Hepatic Gene Regulation

2025 · Rajamanikkam Kamaraj, Ivana Mejdrová, et al. · Journal of Medicinal Chemistry · 11

Off-target lipid metabolism disruption by the mouse constitutive androstane receptor ligand TCPOBOP in humanized mice

2021 · Josef Skoda, Klara Dohnalova, et al. · Biochemical Pharmacology · 11

Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors

2024 · Daniel J. Merk, Foteini Tsiami, et al. · Genome biology · 9

PDF

Defined co-cultures of glutamatergic and GABAergic neurons with a mutation in DISC1 reveal aberrant phenotypes in GABAergic neurons

2024 · Johanna Heider, Aaron Stahl, et al. · BMC Neuroscience · 9

PDF

A multi-omics approach to elucidate okadaic acid-induced changes in human HepaRG hepatocarcinoma cells

2024 · Leonie T. D. Wuerger, Heike Sprenger, et al. · Archives of Toxicology · 8

Genome-wide CRISPR-Cas9 screens identify BCL family members as modulators of response to regorafenib in experimental glioma

2025 · Lara Annina Haeusser, Hannes Becker, et al. · Neuro-Oncology · 7

PDF

Functionally-instructed modifiers of response to ATR inhibition in experimental glioma

2024 · Bianca Walter, Sophie Hirsch, et al. · Journal of Experimental & Clinical Cancer Research · 7

PDF

Adenosine Receptor 3 in Liver Cancer: Expression Variability, Epigenetic Modulation, and Enhanced Histone Deacetylase Inhibitor Effects

2024 · Louise Kaldjob-Heinrich, Sandro Nuciforo, et al. · Gastro Hep Advances · 6

PDF

Multiplexed Serum Antibody Screening Platform Using Virus Extracts from Endemic Coronaviridae and SARS-CoV-2

2021 · Simon Fink, Felix Ruoff, et al. · ACS Infectious Diseases · 6

PDF

The pyrrolizidine alkaloid lasiocarpine impairs cell cycle progression in vitro

2025 · Stefanie Hessel-Pras, Marlena Beckschulte, et al. · Archives of Toxicology · 2

Protein Profiling of Breast Carcinomas Reveals Expression of Immune-Suppressive Factors and Signatures Relevant for Patient Outcome

2022 · Felix Ruoff, Nicolas Kersten, et al. · Cancers · 2

PDF

Pregnane X receptor-mediated liver growth: a controlled clinical trial in healthy volunteers and identification of the role of AKT–MTOR pathway in mouse

2026 · Piia Lassila, Mikko Karpale, et al. · Archives of Toxicology · 1

PDF

A multi‑omics approach to elucidate okadaic acid‑induced changes in human HepaRG hepatocarcinoma cells

2025 · Sprenger, Heike, Würger, Leonie, et al. · OpenAgrar

Js04.7.a Identification of Bcl Family Members as Modulators of Regorafenib Efficacy in Experimental Glioma

2025 · L A Haeusser, H Becker, et al. · Neuro-Oncology

PDF

P19-03 The pyrrolizidine alkaloid lasiocarpine impairs cell cycle progression in vitro

2025 · S. Hessel-Pras, M. Beckschulte, et al. · Toxicology Letters

Discovery of PXR Antagonist MI891 and PXR Degrader MI1013 and Their Roles in Hepatic Gene Regulation

2025 · Kronenberger, Thales, Stahl, Aaron, et al. · Universitätsbibliothek Tübingen

Das molekulare Interaktionsmuster von Lenvatinib ermöglicht die Inhibierung von Cholangiokarzinomen mit wildtype und rezeptormutierten FGFR2-Fusionen

2024 · S. Spahn, F. Kleinhenz, et al. · Zeitschrift für Gastroenterologie

P10.25.a Atr Inhibition in Experimental Glioma: Discovery and Validation of Molecular Targets for Functionally-instructed Combination Therapies

2023 · B Walter, S Hirsch, et al. · Neuro-Oncology

PDF

Exth-74. Atr Inhibition in Experimental Glioma

2022 · Bianca Walter, Leonard Schnabel, et al. · Neuro-Oncology

PDF

Works count: 43

Citation count: 119

H-index: 7

I10-index: 4